News & Events
Novel Vaccine for Ebola & other Hemorrhagic Fever Viruses
A collaboration among research institutions, private industry, and the US Government will develop a tetravalent vaccine to protect against four viruses that can be fatal.
Endometriosis Increases Risk of Complications during Pregnancy & Delivery
A new study shows that pregnant women with endometriosis are at greater risk for a host of complications during pregnancy and delivery, including preterm birth and cesarean section.
Stephen K. Klasko Named to Modern Healthcare’s 100 Most Influential People in Healthcare of 2017
Stephen K. Klasko, MD, MBA, President and CEO of Thomas Jefferson University and Jefferson Health, is named to Modern Healthcare’s 2017 list of the 100 Most Influential People in Healthcare.
Bruce A. Meyer, MD, MBA, to Join Jefferson Health as Chief Physician Executive and Senior Executive Vice President of Thomas Jefferson University
Jefferson announces the appointment of Bruce A. Meyer, MD, MBA, to the newly-created position of chief physician executive of Jefferson Health and senior executive vice president of Thomas Jefferson University.
AACOM Launches Groundbreaking Study on Medical Student Empathy with Thomas Jefferson University & Cleveland Clinic Researchers
The American Association of Colleges of Osteopathic Medicine (AACOM) is sponsoring a groundbreaking nationwide project to study medical student empathy and its relationship to osteopathic medical education (OME) in collaboration with the Sidney Kimmel Medical College at Thomas Jefferson University and Leonard Calabrese, DO, a professor of medicine at Cleveland Clinic Lerner College of Medicine.
Trauma-Informed, Mindfulness-Based Intervention Significantly Improves Parenting among Mothers in Opioid Use Disorder Treatment
Researchers at Jefferson’s Maternal Addiction Treatment Education & Research (MATER) program found significant improvement in the quality of parenting among mothers who participated in a trauma-informed, mindfulness-based parenting intervention while also in medication-assisted treatment for opioid use disorder. Results of the study, the first to scientifically test a mindfulness-based parenting intervention with this population, were published July 27 in the Journal of Addiction Medicine.
Thomas Jefferson University, in Collaboration with ARTZ Philadelphia and Theater of Witness, Awarded Grant from The Pew Center for Arts & Heritage for Empathy Program
Thomas Jefferson University, in collaboration with ARTZ Philadelphia and Theater of Witness, was awarded a $300,000 grant from The Pew Center for Arts & Heritage (PCAH) to build on Jefferson’s growing humanities program which fosters empathy, comfort with ambiguity and the recognition of one’s own limits among health professions students.
Jefferson Researchers Identify New Target for Chronic Pain
Proteins must be in the right place at the right time in the cell to function correctly. This is even more critical in a neuron than in other cells because of its complex tree-like structure and its function. Researchers at Thomas Jefferson University have now discovered how phosphorylation, a common type of protein modification, functions in a novel way to change the location of proteins that are critical for both neuronal function and pathological pain.
Treatment Rapidly Reverses the Effect of Blood Thinner Dabigatran
A new treatment rapidly removes the oral blood thinner dabigatran (PRADAXA®) from circulation within minutes, allowing life-saving clots to form normally.
Official Combination of Philadelphia University & Thomas Jefferson University Signals Disruption in a Stagnant Education Industry
Philadelphia University and Thomas Jefferson University announced their official combination, effective July 1, 2017, creating a comprehensive university designed to deliver high-impact education and value for students in medicine, science, architecture, design, fashion, textiles, health, business, engineering and more.